FDA ACCELERATED APPROVAL REG REQUIRES REPLICATION OF PHASE II FINDINGS; INTERIM RULE APPLIES TO TREATMENTS FOR LIFE-THREATENING, DEBILITATING ILLNESS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".